Trade IDORSIA N - IDIA CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.25 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.015699% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | -0.006523% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | CHF | ||||||||
Margin | 5% | ||||||||
Stock exchange | Switzerland | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Idorsia Ltd ESG Risk Ratings
‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly
Prev. Close* | 2.95 |
Open* | 2.9 |
1-Year Change* | -76.98% |
Day's Range* | 2.8 - 2.95 |
52 wk Range | 10.83-22.16 |
Average Volume (10 days) | 391.73K |
Average Volume (3 months) | 8.30M |
Market Cap | 2.62B |
P/E Ratio | -100.00K |
Shares Outstanding | 177.11M |
Revenue | 48.27M |
EPS | -5.03 |
Dividend (Yield %) | N/A |
Beta | 0.81 |
Next Earnings Date | Feb 7, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Sep 25, 2023 | 2.95 | -0.05 | -1.67% | 3.00 | 3.10 | 2.85 |
Sep 22, 2023 | 3.05 | 0.00 | 0.00% | 3.05 | 3.15 | 3.05 |
Sep 21, 2023 | 3.10 | -0.35 | -10.14% | 3.45 | 3.50 | 3.05 |
Sep 20, 2023 | 3.60 | 0.10 | 2.86% | 3.50 | 3.65 | 3.45 |
Sep 19, 2023 | 3.55 | -0.30 | -7.79% | 3.85 | 3.85 | 3.50 |
Sep 18, 2023 | 3.85 | -0.15 | -3.75% | 4.00 | 4.05 | 3.80 |
Sep 15, 2023 | 4.00 | -0.05 | -1.23% | 4.05 | 4.10 | 3.85 |
Sep 14, 2023 | 4.10 | 0.20 | 5.13% | 3.90 | 4.15 | 3.80 |
Sep 13, 2023 | 3.80 | 0.20 | 5.56% | 3.60 | 3.85 | 3.60 |
Sep 12, 2023 | 3.65 | -0.15 | -3.95% | 3.80 | 3.90 | 3.55 |
Sep 11, 2023 | 3.85 | -0.50 | -11.49% | 4.35 | 4.35 | 3.85 |
Sep 8, 2023 | 4.30 | 0.20 | 4.88% | 4.10 | 4.40 | 4.05 |
Sep 7, 2023 | 4.15 | -0.35 | -7.78% | 4.50 | 4.65 | 4.10 |
Sep 6, 2023 | 4.60 | -0.25 | -5.15% | 4.85 | 4.85 | 4.45 |
Sep 5, 2023 | 5.00 | 0.05 | 1.01% | 4.95 | 5.10 | 4.85 |
Sep 4, 2023 | 5.10 | 0.05 | 0.99% | 5.05 | 5.20 | 4.95 |
Sep 1, 2023 | 5.05 | 0.30 | 6.32% | 4.75 | 5.20 | 4.70 |
Aug 31, 2023 | 4.75 | 0.00 | 0.00% | 4.75 | 4.90 | 4.70 |
Aug 30, 2023 | 4.75 | -0.05 | -1.04% | 4.80 | 4.95 | 4.70 |
Aug 29, 2023 | 4.95 | 0.05 | 1.02% | 4.90 | 5.05 | 4.75 |
IDORSIA N Events
Time (UTC) | Country | Event |
---|---|---|
Tuesday, October 24, 2023 | ||
Time (UTC) 05:00 | Country CH
| Event Q3 2023 Idorsia Ltd Earnings Release Q3 2023 Idorsia Ltd Earnings ReleaseForecast -Previous - |
Monday, February 5, 2024 | ||
Time (UTC) 06:00 | Country CH
| Event Full Year 2023 Idorsia Ltd Earnings Release Full Year 2023 Idorsia Ltd Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 97.102 | 35.349 | 71.758 | 23.819 | 60.618 |
Revenue | 97.102 | 35.349 | 71.758 | 23.819 | 60.618 |
Cost of Revenue, Total | 6.266 | ||||
Gross Profit | 90.836 | ||||
Total Operating Expense | 900.067 | 648.353 | 482.34 | 506.24 | 431.693 |
Selling/General/Admin. Expenses, Total | 504.032 | 230.669 | 96.065 | 63.441 | 60.641 |
Research & Development | 368.331 | 399.208 | 366.076 | 422.526 | 370.083 |
Depreciation / Amortization | 21.437 | 18.476 | 20.2 | 20.273 | 0.97 |
Operating Income | -802.965 | -613.004 | -410.582 | -482.421 | -371.075 |
Interest Income (Expense), Net Non-Operating | -21.865 | -13.644 | -9.717 | -0.404 | -1.581 |
Other, Net | 4.741 | -8.157 | -28.98 | -2.372 | -15.17 |
Net Income Before Taxes | -820.089 | -634.805 | -449.279 | -485.197 | -387.826 |
Net Income After Taxes | -827.896 | -634.595 | -445.119 | -494.649 | -387.512 |
Minority Interest | 0 | 0.328 | 1.04 | 1.121 | |
Net Income Before Extra. Items | -827.896 | -634.595 | -444.791 | -493.609 | -386.391 |
Net Income | -827.896 | -634.595 | -444.791 | -493.609 | -386.391 |
Income Available to Common Excl. Extra. Items | -827.896 | -634.595 | -444.791 | -493.609 | -386.39 |
Income Available to Common Incl. Extra. Items | -827.896 | -634.595 | -444.791 | -493.609 | -386.39 |
Diluted Net Income | -827.896 | -634.595 | -444.791 | -493.609 | -386.39 |
Diluted Weighted Average Shares | 177.434 | 168.498 | 142.809 | 132.949 | 126.45 |
Diluted EPS Excluding Extraordinary Items | -4.66594 | -3.76619 | -3.11459 | -3.71278 | -3.05566 |
Diluted Normalized EPS | -4.66594 | -3.76619 | -3.11459 | -3.71278 | -3.05566 |
Other Operating Expenses, Total | 0.001 | -0.001 | -0.001 | ||
Total Adjustments to Net Income | 0.001 | ||||
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | 0 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 29.93 | 21.025 | 53.813 | 21.028 | 17.078 |
Revenue | 29.93 | 21.025 | 53.813 | 21.028 | 17.078 |
Total Operating Expense | 206.936 | 218.615 | 246.569 | 226.605 | 229.165 |
Selling/General/Admin. Expenses, Total | 123.435 | 123.501 | 137.213 | 136.616 | 129.605 |
Research & Development | 74.724 | 89.84 | 101.226 | 82.245 | 93.981 |
Depreciation / Amortization | 4.416 | 4.42 | 5.4 | 5.46 | 4.326 |
Other Operating Expenses, Total | -0.001 | 0.001 | 0.001 | 0.002 | -0.002 |
Operating Income | -177.006 | -197.59 | -192.756 | -205.577 | -212.087 |
Interest Income (Expense), Net Non-Operating | -2.659 | -11.577 | -4.598 | -3.646 | -3.875 |
Other, Net | -12.501 | -2.102 | 7.063 | -3.969 | -4.223 |
Net Income Before Taxes | -192.166 | -211.269 | -190.291 | -213.192 | -220.185 |
Net Income After Taxes | -193.11 | -212.183 | -192.813 | -215.951 | -221.578 |
Minority Interest | |||||
Net Income Before Extra. Items | -193.11 | -212.183 | -192.813 | -215.951 | -221.578 |
Net Income | -193.11 | -212.183 | -192.813 | -215.951 | -221.578 |
Income Available to Common Excl. Extra. Items | -193.111 | -212.183 | -192.813 | -215.951 | -221.577 |
Income Available to Common Incl. Extra. Items | -193.111 | -212.183 | -192.813 | -215.951 | -221.577 |
Diluted Net Income | -193.111 | -212.183 | -192.813 | -215.951 | -221.577 |
Diluted Weighted Average Shares | 178.265 | 177.984 | 177.548 | 177.528 | 177.511 |
Diluted EPS Excluding Extraordinary Items | -1.08328 | -1.19215 | -1.08598 | -1.21644 | -1.24824 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | 0 |
Diluted Normalized EPS | -1.08328 | -1.19215 | -1.08598 | -1.21644 | -1.24824 |
Total Adjustments to Net Income | -0.001 | 0.001 | |||
Cost of Revenue, Total | 4.362 | 0.853 | 2.729 | 2.282 | 1.255 |
Gross Profit | 25.568 | 20.172 | 51.084 | 18.746 | 15.823 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 596.438 | 1077.46 | 1034.63 | 775.401 | 941.422 |
Cash and Short Term Investments | 476.324 | 1038.12 | 1010.03 | 739.286 | 921.422 |
Cash & Equivalents | 50 | 263.007 | 798.557 | ||
Total Receivables, Net | 49.348 | 16.697 | 10.609 | 5.951 | 2.11 |
Accounts Receivable - Trade, Net | 4.323 | 4.611 | 4.568 | 5.951 | 2.11 |
Total Inventory | 35.84 | ||||
Other Current Assets, Total | 1.703 | 0.923 | 1.098 | 30.164 | 17.89 |
Total Assets | 904.18 | 1482.96 | 1435.36 | 1004.2 | 1406.77 |
Property/Plant/Equipment, Total - Net | 245.468 | 223.435 | 196.224 | 206.726 | 150.697 |
Goodwill, Net | |||||
Intangibles, Net | 14.756 | 6.131 | 0.583 | 1.694 | 2.807 |
Other Long Term Assets, Total | 47.518 | 15.88 | 9.457 | 8.983 | 6.633 |
Total Current Liabilities | 170.364 | 165.14 | 127.467 | 110.879 | 104.853 |
Accounts Payable | 25.435 | 26.86 | 11.117 | 8.76 | 7.131 |
Accrued Expenses | 133.715 | 123.181 | 98.83 | 83.706 | 67.576 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 11.214 | 15.099 | 17.52 | 18.413 | 30.146 |
Total Liabilities | 1565.14 | 1378.75 | 849.882 | 831.756 | 742.087 |
Total Long Term Debt | 1129.79 | 1092.61 | 587.352 | 579.002 | 570.842 |
Long Term Debt | 1129.79 | 1092.61 | 587.352 | 579.002 | 570.842 |
Minority Interest | 0 | -8.098 | -7.058 | ||
Other Liabilities, Total | 258.512 | 119.997 | 130.298 | 136.312 | 67.432 |
Total Equity | -660.958 | 104.204 | 585.483 | 172.444 | 664.683 |
Common Stock | 8.878 | 8.848 | 8.324 | 6.562 | 6.553 |
Additional Paid-In Capital | 2126.86 | 2100.24 | 1962.74 | 1083.68 | 1065.23 |
Retained Earnings (Accumulated Deficit) | -2845.1 | -1982.08 | -1347.48 | -894.268 | -400.659 |
Treasury Stock - Common | |||||
Other Equity, Total | 48.403 | -22.802 | -38.096 | -23.527 | -6.439 |
Total Liabilities & Shareholders’ Equity | 904.18 | 1482.96 | 1435.36 | 1004.2 | 1406.77 |
Total Common Shares Outstanding | 177.559 | 176.967 | 166.482 | 133.003 | 132.341 |
Short Term Investments | 330.326 | 936.773 | 869.215 | 476.279 | 122.865 |
Property/Plant/Equipment, Total - Gross | 342.361 | 305.349 | 260.827 | 179.289 | |
Accumulated Depreciation, Total | -96.893 | -81.913 | -64.603 | -46.974 | -28.592 |
Long Term Investments | 0 | 160.05 | 194.474 | 11.396 | 305.211 |
Deferred Income Tax | 6.468 | 1.008 | 4.765 | 13.661 | 6.018 |
Cash | 145.998 | 101.352 | 90.81 | ||
Prepaid Expenses | 33.223 | 21.717 | 12.895 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 374.829 | 596.438 | 776.583 | 807.889 | 1007.07 |
Cash and Short Term Investments | 220.018 | 476.324 | 700.031 | 739.623 | 950.547 |
Cash & Equivalents | |||||
Short Term Investments | 8.327 | 330.326 | 385.208 | 506.644 | 804.884 |
Total Receivables, Net | 48.71 | 49.348 | 23.091 | 25.476 | 3.902 |
Accounts Receivable - Trade, Net | 2.501 | 4.323 | 3.853 | 16.085 | 3.902 |
Other Current Assets, Total | 45.944 | 34.926 | 34.671 | 26.331 | 45.397 |
Total Assets | 698.363 | 904.18 | 1024.78 | 1059.4 | 1256.75 |
Property/Plant/Equipment, Total - Net | 242.403 | 245.468 | 219.753 | 224.785 | 221.965 |
Intangibles, Net | 14.663 | 14.756 | 14.762 | 13.221 | 12.587 |
Long Term Investments | 0 | 0 | 0 | 0 | |
Other Long Term Assets, Total | 66.468 | 47.518 | 13.678 | 13.507 | 15.127 |
Total Current Liabilities | 165.937 | 170.364 | 166.012 | 158.315 | 147.661 |
Accounts Payable | 27.107 | 25.435 | 19.367 | 21.084 | 17.862 |
Accrued Expenses | 125.795 | 133.715 | 134.947 | 125.905 | 118.319 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 13.035 | 11.214 | 11.698 | 11.326 | 11.48 |
Total Liabilities | 1558.62 | 1565.14 | 1567.83 | 1395.4 | 1377.41 |
Total Long Term Debt | 1130.06 | 1129.79 | 1129.53 | 1129.27 | 1129 |
Long Term Debt | 1130.06 | 1129.79 | 1129.53 | 1129.27 | 1129 |
Deferred Income Tax | 6.59 | 6.468 | 1.62 | 0 | 0 |
Minority Interest | |||||
Other Liabilities, Total | 256.033 | 258.512 | 270.67 | 107.815 | 100.748 |
Total Equity | -860.255 | -660.958 | -543.056 | -335.994 | -120.662 |
Common Stock | 9.396 | 8.878 | 8.877 | 8.876 | 8.875 |
Additional Paid-In Capital | 2139.33 | 2126.86 | 2119.64 | 2111.94 | 2106.33 |
Retained Earnings (Accumulated Deficit) | -3057.28 | -2845.1 | -2652.28 | -2436.33 | -2214.76 |
Other Equity, Total | 48.778 | 48.403 | -19.291 | -20.477 | -21.109 |
Total Liabilities & Shareholders’ Equity | 698.363 | 904.18 | 1024.78 | 1059.4 | 1256.75 |
Total Common Shares Outstanding | 187.914 | 177.559 | 177.541 | 177.525 | 177.5 |
Cash | 211.691 | 145.998 | 314.823 | 232.979 | 145.663 |
Total Inventory | 60.157 | 35.84 | 18.79 | 16.459 | 7.225 |
Treasury Stock - Common | -0.483 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -827.896 | -634.595 | -445.119 | -494.649 | -387.511 |
Cash From Operating Activities | -859.107 | -589.895 | -364.666 | -462.039 | -352.817 |
Cash From Operating Activities | 19.829 | 18.033 | 18.925 | 19.693 | 19.563 |
Non-Cash Items | 12.491 | 32.894 | 32.066 | 0.257 | 3.063 |
Changes in Working Capital | -64.697 | -0.841 | 35.52 | 6.229 | 14.001 |
Cash From Investing Activities | 743.901 | -53.257 | -607.131 | -74.807 | 31.193 |
Capital Expenditures | -27.058 | -30.931 | -9.286 | -18.991 | -14.266 |
Cash From Financing Activities | 162.31 | 604.146 | 850.076 | 1.33 | 497.764 |
Issuance (Retirement) of Stock, Net | 0.36 | 9.582 | 850.077 | 1.33 | 299.449 |
Issuance (Retirement) of Debt, Net | 0 | 594.564 | 0 | 198.315 | |
Foreign Exchange Effects | -2.457 | -0.452 | -0.476 | -0.034 | -0.035 |
Net Change in Cash | 44.647 | -39.458 | -122.197 | -535.55 | 176.105 |
Deferred Taxes | 1.166 | -5.386 | -6.058 | 6.431 | -1.933 |
Other Investing Cash Flow Items, Total | 770.959 | -22.326 | -597.845 | -55.816 | 45.459 |
Financing Cash Flow Items | 161.95 | -0.001 | 0 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -212.183 | -827.896 | -635.083 | -419.132 | -197.555 |
Cash From Operating Activities | -250.046 | -859.107 | -638.125 | -442.311 | -237.928 |
Cash From Operating Activities | 4.565 | 19.829 | 14.151 | 9.712 | 5.192 |
Deferred Taxes | 0.768 | 1.166 | 2.139 | 0.577 | 0.373 |
Non-Cash Items | 16.651 | 12.491 | 13.202 | 8.327 | -1.182 |
Changes in Working Capital | -59.847 | -64.697 | -32.534 | -41.795 | -44.756 |
Cash From Investing Activities | 316.405 | 743.901 | 687.521 | 572.703 | 281.247 |
Capital Expenditures | -3.595 | -27.058 | -23.438 | -18.263 | -13.101 |
Other Investing Cash Flow Items, Total | 320 | 770.959 | 710.959 | 590.966 | 294.348 |
Cash From Financing Activities | -0.083 | 162.31 | 162.31 | 0.36 | 0.241 |
Issuance (Retirement) of Stock, Net | -0.083 | 0.36 | 0.36 | 0.36 | 0.241 |
Foreign Exchange Effects | -0.584 | -2.457 | 1.765 | 0.875 | 0.751 |
Net Change in Cash | 65.692 | 44.647 | 213.471 | 131.627 | 44.311 |
Issuance (Retirement) of Debt, Net | 0 | 0 | |||
Financing Cash Flow Items | 161.95 | 161.95 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
IDORSIA Company profile
Idorsia LtdIndustry: | Bio Therapeutic Drugs |
Hegenheimermattweg 91
ALLSCHWIL
BASEL-LANDSCHAFT 4123
CH
Income Statement
- Annual
- Quarterly
News

USD/JPY Climbs Towards Key Highs
USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.
11:32, 26 September 2023
EUR/USD tests key support
EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.
14:32, 21 September 2023
BoE leaves rates unchanged, GBP drops further as investors look for more clarity
The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August
11:45, 21 September 2023
GBP softer after CPI surprise, JPY focused on any further hints from Ueda
GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.
12:42, 20 September 2023
How to Trade The Break & Retest
In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.
11:59, 20 September 2023
Cable coils near lows ahead of Fed and BoE rate decisions
It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.
14:16, 19 September 2023
FTSE 100 Technical Outlook - 18 September 2023
In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.
06:55, 19 September 2023People also watch
Still looking for a broker you can trust?
Join the 555.000+ traders worldwide that chose to trade with Capital.com